Insider · CIK 0001828400
Charles Douglas McLane Jr
director
Files at CRS (CARPENTER TECHNOLOGY CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +361 | - | - | 25,682 | 4 d ago |
| Oct 6, 2026 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Option (Right to Buy)derivative | +193 | - | - | 193 | 4 d ago |
| Sep 30, 2026 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +69 | $388.82 | $27k | 25,321 | 10 d ago |
| Oct 7, 2025 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +557 | - | - | 25,005 | Oct 9, 2025 |
| Oct 7, 2025 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Option (Right to Buy)derivative | +304 | - | - | 304 | Oct 9, 2025 |
| Sep 30, 2025 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +102 | $245.54 | $25k | 24,448 | Oct 2, 2025 |
| Jun 30, 2025 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +90 | $276.38 | $25k | 24,327 | Jul 2, 2025 |
| Mar 31, 2025 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +138 | $181.18 | $25k | 24,219 | Apr 2, 2025 |
| Dec 31, 2024 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +147 | $169.71 | $25k | 24,054 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.